Screener
Agilent Technologies A Trading Securities in Marketable Securities
Trading Securities in Marketable Securities at other companies
Other financials
Where this comes from
Reported directly by Agilent Technologies in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.
The source filing: Agilent Technologies’s 10-Q, filed June 1, 2026.
- Filed
- Jun 1, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001090872-26-000055
As of April 30, 2026, the cumulative net gain (loss) on our non-marketable equity securities without readily determinable fair values was comprised of $42 million upward adjustments, $72 million downward adjustments and $26 million of impairments. As of April 30, 2026, the carrying amount of our non-marketable equity securities without readily determinable fair value was $54 million.
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Agilent Technologies's trading securities in marketable securities?
- Agilent Technologies (A) reported trading securities in marketable securities of $54M in Q1 2026.
- How has Agilent Technologies's trading securities in marketable securities changed year-over-year?
- Agilent Technologies's trading securities in marketable securities decreased by 11.5% year-over-year, from $61M to $54M.
- What is the long-term trend for Agilent Technologies's trading securities in marketable securities?
- Over 4 years (2020 to 2024), Agilent Technologies's trading securities in marketable securities has grown at a -0.5% compound annual growth rate (CAGR), from $103M to $101M.
Ask your AI about Agilent Technologies's trading securities in marketable securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude